Strata Skin Sciences, Inc. SSKN

0.01 0.00 0.00% as of 25 Sep
Market cap
$1.0M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
0.02 0.01 0.17 0.21 0.22 0.17 0.08 0.54 0.33 0.19
P/FCF ratio
1.60 0.09 1.77 3.16 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
0.34 0.18 4.63 5.98 14.57 7.48 15.51 13.24 15.76 (24.52)
P/B ratio
0.03 0.02 0.16 0.23 0.19 0.20 0.13 1.43 2.23 2.02
Price to Tangible BV
0.00 0.00 0.40 0.56 0.47 0.77 0.00 0.00 0.00 0.00
EV/Sales
0.65 0.21 (0.13) (0.01) (0.46) 0.00 0.11 0.76 0.54 0.87
EV/EBITDA
3.68 1.15 0.00 0.00 63.89 0.00 3.19 0.00 0.00 0.00
EV/Operating CF
62.24 1.57 (1.38) (0.14) (5.03) 0.04 (4.13) (49.11) 96.17 (9.57)
EV/FCF
67.26 1.71 (1.39) (0.15) 60.94 (0.03) (0.82) (4.60) (12.49) (6.27)
Quick Ratio
1.19 0.69 2.31 1.15 1.12 1.25 0.84 1.03 1.03 0.45
Current Ratio
1.75 1.03 2.69 1.35 1.32 1.56 1.12 1.28 1.24 0.58
Net Debt/EBITDA
3.60 1.09 (4.13) (3.51) 94.45 17.74 0.87 (2.70) (1.74) (97.86)
Debt/Assets
54.39% 26.17% 15.57% 18.30% 5.40% 16.39% 14.98% 35.81% 43.50% 50.29%
Debt/Equity
1.60 0.52 0.24 0.30 0.10 0.30 0.36 1.19 3.06 5.28
Asset Turnover
0.66 0.77 0.69 0.67 0.49 0.64 0.73 0.71 0.87 0.94
Operating CF/Net income
(0.10) (0.19) (0.72) (0.59) (0.48) (0.56) 0.17 0.05 (0.02) 0.45
Capex/Depreciation
0.00 (0.04) 0.00 (0.02) (0.55) (0.89) (0.64) (0.83) (0.30) (0.32)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(21.65%) (124.38%) (15.78%) (12.65%) (16.11%) (10.55%) (23.49%) (62.75%) (114.22%) (158.91%)
ROA
(7.15%) (52.27%) (9.31%) (7.99%) (9.34%) (5.80%) (11.23%) (22.97%) (26.22%) (19.13%)
ROIC
(6.56%) (4.32%) (9.46%) (8.67%) (24.71%) (13.44%) (12.71%) (27.42%) (50.00%) (28.40%)
Return on Tangible Assets
(22.54%) (269.53%) (20.27%) (32.99%) (38.14%) (19.26%) (47.94%) (71.50%) (76.06%) 287.60%
Average Days of Receivables
40.30 36.09 41.48 50.68 46.54 41.80 45.13 48.58 57.13 49.00
Research and Development Expense of Revenue
6.28% 5.39% 3.57% 3.17% 5.52% 4.78% 2.85% 3.95% 2.63% 1.37%
Selling, General and Administrative Expense of Revenue
64.28% 59.36% 65.01% 70.53% 73.35% 76.12% 70.21% 70.34% 69.50% 75.89%
Intangible Assets out of Total Assets
0.51 0.53 0.39 0.35 0.32 0.41 0.50 0.33 0.19 0.16
Share Based Compensation of Revenue
0.37% 0.59% 3.03% 3.78% 7.07% 5.48% 4.05% 3.91% 1.27% 2.09%
Graham Net Nets
(37.17) (24.85) 1.36 0.73 0.78 (0.24) (5.54) (0.76) (1.21) (2.05)
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(688.89%) (5,690.48%) (79.19%) (61.50%) (86.67%) (51.20%) (193.21%) (59.62%) (92.44%) (111.90%)
Free Cash Flow Yield
62.50% 1,117.08% 56.61% 31.68% (3.43%) (42.85%) (167.81%) (30.50%) (13.07%) (72.73%)
Revenue per Share
144.91 117.03 15.24 9.88 6.87 8.80 10.42 9.55 8.82 6.60
Operating CF per Share
1.52 15.25 1.48 0.70 0.62 0.44 (0.27) (0.15) 0.05 (0.60)
Capex per Share
0.00 (1.18) (0.01) (0.04) (0.64) (1.07) (1.08) (1.44) (0.43) (0.32)
Free Cash Flow per Share
1.52 14.08 1.47 0.66 (0.02) (0.63) (1.34) (1.59) (0.38) (0.92)
Cash per Share
18.54 14.99 8.42 4.89 5.39 3.70 1.96 2.32 2.26 1.70
Shareholders Equity per Share
69.46 73.25 15.95 8.96 7.70 7.46 6.29 3.63 1.31 0.63
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
69.46 73.25 15.95 8.96 7.70 7.46 6.29 3.63 1.31 0.63
Free Cash Flow
0.32 3.82 2.88 2.11 (0.06) (2.14) (4.66) (5.54) (1.45) (4.26)
Working Capital
4.62 0.28 14.60 6.12 5.99 7.17 1.63 3.37 3.20 (11.14)
Capital Expenditures
(1.01) (0.32) (0.01) (0.11) (2.16) (3.65) (3.74) (5.02) (1.64) (1.47)
Net Current Asset Value
(17.72) (8.50) 6.95 4.87 3.95 (1.21) (15.39) (13.78) (13.36) (12.01)
EV/EBIT
0.00 0.00 1.19 0.10 2.59 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.00 0.01 0.00 0.00 0.09 0.12 0.10 0.15 0.05 0.05
Net Profit Margin
(10.86%) (67.73%) (13.51%) (12.00%) (19.03%) (9.03%) (15.35%) (32.47%) (30.05%) (20.40%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.89 0.97 1.05 0.93 0.71 0.60 0.59 0.51 0.54 0.52
Cash ROIC
(23.39%) (10.42%) (4.36%) (5.93%) (7.38%) (11.78%) (29.83%) (34.30%) (34.33%) (44.93%)
Accounts Receivable Turnover
8.23 9.73 9.14 8.12 6.30 9.40 9.15 7.49 6.93 6.55
Accounts Payable Turnover
4.01 6.29 6.30 6.21 3.86 3.63 4.61 4.40 4.97 4.94
Inventory Turnover
3.64 4.46 4.39 3.89 2.77 2.92 4.37 5.17 5.83 5.07
Average Days of Payables
53.53 63.94 50.56 60.64 112.65 101.71 86.86 81.91 61.93 78.55
Days of Inventory on Hand
81.37 84.50 80.08 97.64 140.36 125.75 78.49 65.49 57.17 80.15
Average Receivables
3.73 3.27 3.27 3.89 3.67 3.19 3.95 4.46 4.85 4.69
Average Payables
3.15 2.07 2.02 1.82 2.32 2.79 3.12 3.38 2.89 2.60
Average Inventory
3.47 2.91 2.90 2.91 3.24 3.47 3.29 2.88 2.46 2.53
Average Assets
46.64 41.16 43.32 47.43 47.06 46.69 49.43 47.14 38.47 32.72
Average Common Equity
15.40 17.30 25.56 29.95 27.27 25.65 23.62 17.26 8.83 3.94

Fold the line items

Columns are period end dates